Guidelines for Mass Screening of Congenital Hypothyroidism (2014 revision)

この論文にアクセスする

この論文をさがす

著者

抄録

Purpose of developing the guidelines: Mass screening for congenital hypothyroidism started in 1979 in Japan, and the prognosis for intelligence has been improved by early diagnosis and treatment. The incidence was about 1/4000 of the birth population, but it has increased due to diagnosis of subclinical congenital hypothyroidism. The disease requires continuous treatment, and specialized medical facilities should make a differential diagnosis and treat subjects who are positive in mass screening to avoid unnecessary treatment. The Guidelines for Mass Screening of Congenital Hypothyroidism (1998 version) were developed by the Mass Screening Committee of the Japanese Society for Pediatric Endocrinology in 1998. Subsequently, new findings on prognosis and problems in the adult phase have emerged. Based on these new findings, the 1998 guidelines were revised in the current document (hereinafter referred to as the Guidelines). Target disease/conditions: Primary congenital hypothyroidism. Users of the Guidelines: Physician specialists in pediatric endocrinology, pediatric specialists, physicians referring patients to pediatric practitioners, general physicians, laboratory technicians in charge of mass screening, and patients.

収録刊行物

  • Clinical Pediatric Endocrinology

    Clinical Pediatric Endocrinology 24(3), 107-133, 2015

    The Japanese Society for Pediatric Endocrinology

各種コード

  • NII論文ID(NAID)
    130005088095
  • 本文言語コード
    EN
  • ISSN
    0918-5739
  • データ提供元
    J-STAGE 
ページトップへ